NGS identified a new JAK3 p.M511I mutation in the recurrent skin tumor and new JAK1 p.L783F and subclonal JAK1 p.T901A mutations in the blood (Figure 1, G and I, and Supplemental Figure 2A). This evidence concerns the gene JAK1 and skin neoplasm.